Unknown

Dataset Information

0

Screening for brain metastases in patients with advanced non-small cell lung cancer and an actionable genomic alteration: A structured literature review

ABSTRACT:

SUBMITTER:  

PROVIDER: S-EPMC12349771 | biostudies-literature | 2025 Feb

REPOSITORIES: biostudies-literature

Json Xml

Similar Datasets

Unknown Differences in actionable genomic alterations between brain metastases and non‑brain metastases in patients with non‑small cell lung cancer.
| S-EPMC9291252 | biostudies-literature
Unknown Genomic landscape and actionable mutations of brain metastases derived from non-small cell lung cancer: A systematic review.
| S-EPMC10734675 | biostudies-literature
Unknown Integrated genomic and DNA methylation analysis of patients with advanced non-small cell lung cancer with brain metastases.
| S-EPMC8710019 | biostudies-literature
Unknown Brain Metastases from Lung Cancer: Is MET an Actionable Target?
| S-EPMC6468667 | biostudies-literature
Unknown Clinicopathologic and Genomic Landscape of Non-Small Cell Lung Cancer Brain Metastases.
| S-EPMC9526503 | biostudies-literature
Unknown Single-cell and spatial genomic landscape of non-small cell lung cancer brain metastases.
| S-EPMC12323702 | biostudies-literature
Unknown Stratification of radiosensitive brain metastases based on an actionable S100A9/RAGE resistance mechanism.
| S-EPMC9018424 | biostudies-literature
Unknown Genetics Visit Uptake Among Individuals Receiving Clinically Actionable Genomic Screening Results.
| S-EPMC10943406 | biostudies-literature
Unknown Clinical outcomes of a genomic screening program for actionable genetic conditions.
| S-EPMC7605431 | biostudies-literature
Genomics Genomic Characterization of Brain Metastases
| PRJNA578190 | ENA